• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺癌中p185(HER-2/neu)蛋白的定量分析及其与其他预后因素的关系。

Quantitative analysis of p185(HER-2/neu) protein in breast cancer and its association with other prognostic factors.

作者信息

Valerón P F, Chirino R, Vega V, Falcón O, Rivero J F, Torres S, León L, Fernández L, Pestano J, Díaz-Chico B, Díaz-Chico J C

机构信息

Department of Cellular and Molecular Endocrinology, University of Las Palmas de Gran Canaria, Canary Islands, Spain.

出版信息

Int J Cancer. 1997 Apr 22;74(2):175-9. doi: 10.1002/(sici)1097-0215(19970422)74:2<175::aid-ijc6>3.0.co;2-w.

DOI:10.1002/(sici)1097-0215(19970422)74:2<175::aid-ijc6>3.0.co;2-w
PMID:9133451
Abstract

The total cellular p185(HER-2/neu) protein (p185) content was measured by ELISA in 346 invasive primary breast cancers, and the results were compared with those of estrogen (ER) and progesterone (PR) receptors, pS2 and Cathepsin D (Cat D) content. At a cut-off level of 260 fmol/mg protein, 53 of the 346 tumors (15%) were p185-positive. A significant positive correlation was observed between p185 levels and those of Cat D, and a weaker, though significant, positive correlation with ER, and pS2 levels, but not with those of PR. However, when only the 293 p185-negative tumors were considered, the correlation between p185 and ER improved substantially, and statistical significance was reached for PR. p185-positive tumors exhibited lower ER and PR content and higher Cat D content than p185-negative tumors. The pS2 content, in contrast, did not undergo significant variation. Tumors considered to be p185-positive were significantly more frequently positive for Cat D at the cut-off of 45 pmol/mg protein, and were more frequently negative for ER and/or PR, but only significant at the cut-off of 15 fmol/mg or higher for both steroid receptors. Finally, p185 status was not associated with menopausal status, tumor size, axillary-lymph-node invasiveness or distant metastases. These results suggest that 260 fmol/mg protein as the cut-off for p185 allows the identification of a tumoral sub-population with a more aggresive phenotype.

摘要

采用酶联免疫吸附测定法(ELISA)检测了346例浸润性原发性乳腺癌细胞中总p185(HER-2/neu)蛋白(p185)含量,并将结果与雌激素(ER)、孕激素(PR)受体、pS2和组织蛋白酶D(组织蛋白酶D)含量进行比较。在蛋白含量截断值为260 fmol/mg时,346例肿瘤中有53例(15%)p185呈阳性。观察到p185水平与组织蛋白酶D水平之间存在显著正相关,与ER和pS2水平呈较弱但显著的正相关,与PR水平无相关性。然而,仅考虑293例p185阴性肿瘤时,p185与ER之间的相关性显著改善,PR也具有统计学意义。p185阳性肿瘤的ER和PR含量低于p185阴性肿瘤,组织蛋白酶D含量高于p185阴性肿瘤。相比之下,pS2含量没有显著变化。在蛋白含量截断值为45 pmol/mg时,被认为p185阳性的肿瘤组织蛋白酶D阳性的频率显著更高,ER和/或PR阴性的频率也更高,但仅在两种甾体受体截断值为15 fmol/mg或更高时具有统计学意义。最后,p185状态与绝经状态、肿瘤大小、腋窝淋巴结浸润或远处转移无关。这些结果表明,以260 fmol/mg蛋白作为p185的截断值,可以识别出具有更具侵袭性表型的肿瘤亚群。

相似文献

1
Quantitative analysis of p185(HER-2/neu) protein in breast cancer and its association with other prognostic factors.乳腺癌中p185(HER-2/neu)蛋白的定量分析及其与其他预后因素的关系。
Int J Cancer. 1997 Apr 22;74(2):175-9. doi: 10.1002/(sici)1097-0215(19970422)74:2<175::aid-ijc6>3.0.co;2-w.
2
Enzyme-linked immunosorbent assay of HER-2/neu gene product (p185) in breast cancer: its correlation with sex steroid receptors, cathepsin D and histologic grades.
Cancer Lett. 1993 Dec 20;75(3):195-206. doi: 10.1016/0304-3835(93)90062-e.
3
Immunoradiometric detection of pS2 and total cathepsin D in primary breast cancer biopsies: their correlation with steroid receptors.原发性乳腺癌活检中pS2和总组织蛋白酶D的免疫放射分析检测:它们与类固醇受体的相关性
Br J Cancer. 1994 Mar;69(3):550-4. doi: 10.1038/bjc.1994.100.
4
Quantitative association between HER-2/neu and steroid hormone receptors in hormone receptor-positive primary breast cancer.激素受体阳性原发性乳腺癌中HER-2/neu与类固醇激素受体之间的定量关联
J Natl Cancer Inst. 2003 Jan 15;95(2):142-53. doi: 10.1093/jnci/95.2.142.
5
[Cytosolic pS2 levels and cellular proliferation in ER-positive and PgR-positive infiltrating ductal carcinomas of the breast].[乳腺雌激素受体阳性和孕激素受体阳性浸润性导管癌中的细胞溶质pS2水平与细胞增殖]
Rev Esp Med Nucl. 2005 May-Jun;24(3):185-90. doi: 10.1157/13073789.
6
Steroid receptors, pS2 and cathepsin D in early clinically node-negative breast cancer.早期临床淋巴结阴性乳腺癌中的类固醇受体、pS2和组织蛋白酶D
Eur J Cancer. 1994;30A(1):5-11. doi: 10.1016/s0959-8049(05)80008-5.
7
Prognostic impact of cathepsin D and c-erbB-2 oncoprotein in a subgroup of node-negative breast cancer patients with low histological grade tumors.组织学分级低的淋巴结阴性乳腺癌患者亚组中组织蛋白酶D和c-erbB-2癌蛋白的预后影响
Int J Oncol. 2001 Apr;18(4):793-800.
8
[Study of the cytosolic concentrations of the tissue poly-peptide specific (TPS) antigen in infiltrating ductal carcinomas of the breast. Positive relationship with hormone dependency and negative with cellular proliferation].[乳腺浸润性导管癌中组织多肽特异性(TPS)抗原胞浆浓度的研究。与激素依赖性呈正相关,与细胞增殖呈负相关]
Rev Esp Med Nucl. 2001 Aug;20(5):365-8. doi: 10.1016/s0212-6982(01)71975-1.
9
Prognostic value of the quantitative measurement of the oncoprotein p185(Her-2/neu) in a group of patients with breast cancer and positive node involvement.一组伴有阳性淋巴结转移的乳腺癌患者中癌蛋白p185(Her-2/neu)定量检测的预后价值
Int J Cancer. 2002 Oct 20;101(6):539-44. doi: 10.1002/ijc.10612.
10
[Immunohistochemical detection of pS2 protein in paraffin sections of breast carcinoma tissue. Comparison with results of an immunoradiometry assay].[乳腺癌组织石蜡切片中pS2蛋白的免疫组织化学检测。与免疫放射分析结果的比较]
Pathologe. 1995 Jul;16(4):278-84. doi: 10.1007/s002920050102.

引用本文的文献

1
Clinical significance of the quantitative assessment of the cytosolic concentration of HER-2/neu protein in breast cancer by immunoenzymatic assay (ELISA).免疫酶测定法(ELISA)对乳腺癌中HER-2/neu蛋白胞浆浓度进行定量评估的临床意义。
J Cancer Res Clin Oncol. 2005 Nov;131(11):701-14. doi: 10.1007/s00432-005-0022-3. Epub 2005 Nov 1.